Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$35.86 - $46.5 $26,249 - $34,038
732 Added 6.28%
12,391 $503,000
Q4 2022

Feb 13, 2023

BUY
$35.49 - $56.15 $413,777 - $654,652
11,659 New
11,659 $524,000
Q2 2022

Aug 12, 2022

BUY
$53.22 - $123.09 $5.1 Million - $11.8 Million
95,841 Added 28.82%
428,340 $25.4 Million
Q1 2022

May 11, 2022

BUY
$101.89 - $150.09 $7.01 Million - $10.3 Million
68,811 Added 26.1%
332,499 $38.7 Million
Q4 2021

Feb 07, 2022

BUY
$118.18 - $153.21 $5.61 Million - $7.27 Million
47,473 Added 21.96%
263,688 $39.7 Million
Q3 2021

Nov 10, 2021

SELL
$93.51 - $129.4 $12.9 Million - $17.8 Million
-137,830 Reduced 38.93%
216,215 $25.8 Million
Q2 2021

Aug 05, 2021

SELL
$77.0 - $100.19 $5.21 Million - $6.78 Million
-67,710 Reduced 16.05%
354,045 $34.5 Million
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $21.1 Million - $27.1 Million
-259,495 Reduced 38.09%
421,755 $37.2 Million
Q4 2020

Feb 12, 2021

BUY
$86.4 - $121.75 $1.64 Million - $2.32 Million
19,034 Added 2.87%
681,250 $65.2 Million
Q3 2020

Nov 13, 2020

SELL
$95.43 - $116.09 $2.99 Million - $3.63 Million
-31,284 Reduced 4.51%
662,216 $75.2 Million
Q2 2020

Aug 13, 2020

SELL
$60.05 - $98.92 $3.25 Million - $5.35 Million
-54,112 Reduced 7.24%
693,500 $68.6 Million
Q1 2020

May 14, 2020

BUY
$47.37 - $90.04 $11.4 Million - $21.6 Million
239,901 Added 47.25%
747,612 $48.1 Million
Q4 2019

Feb 12, 2020

BUY
$53.13 - $71.19 $2.44 Million - $3.27 Million
45,972 Added 9.96%
507,711 $30.3 Million
Q3 2019

Nov 13, 2019

BUY
$57.11 - $73.3 $26.4 Million - $33.8 Million
461,739 New
461,739 $27.2 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.